Pavion Blue Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Pavion Blue Capital's PFE Position: Q1 2026 in Review
Pavion Blue Capital opened a new position in Pfizer (PFE) in Q1 2026: 7,422 shares worth $208K. The stake represents 0.09% of the portfolio and ranks #104 among its holdings. This is a return to the name: Pavion Blue Capital previously reported a position in PFE as recently as Q3 2025.
Pavion Blue Capital first reported a position in PFE in Q1 2020 and has held it in 22 quarters since. The position peaked at $633K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Pavion Blue Capital held 7,422 shares of Pfizer worth $208K as of Q1 2026.
- Pfizer was a new Pavion Blue Capital position in Q1 2026.
- Pfizer made up 0.09% of Pavion Blue Capital's portfolio in Q1 2026, its #104 holding.
- Pavion Blue Capital first reported a position in Pfizer in Q1 2020 and has held it in 22 quarters since.
- Pavion Blue Capital's Pfizer position peaked at $633K in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.